Point by Point: The Sale of Dental Practices, Raising Capital and More with Logan Growth Advisors
Five Steps a Healthcare Banker Recommends When Acquiring a Medical or Dental Practice
Legal Steps For Dentists to Follow When Buying or Selling a Practice
Build Out Or Buy? Financing Real Estate Transactions in Healthcare Practices
Structuring DSO/MSO Healthcare Ventures and Practice Acquisitions
Marriage and Divorce Considerations for Health Care Providers
How Private Equity Firms Structure Health Care Mergers and Tax Implications
Health Care Practices: Can They Seek Employee Retention Credits Based on Harm Caused By COVID-19?
Tips for Dentists Starting or Acquiring a Dental Practice
Physician and Dental Practice Branding - A Legal Perspective
The rise of dental spas, offering both dental care and injections of Botox, Juvéderm, and Restylane, for purely aesthetic, cosmetic purposes unrelated to any dental treatment or care, presents a complex legal landscape that...more
Part II of our New Jersey Regulatory Update further identifies proposed and adopted regulations that may impact healthcare providers, from additional financial transparency rules impacting facilities to rules attempting to...more
Mark your calendar for the 2024 McGuireWoods Healthcare Private Equity and Finance Conference, and help us celebrate 20 years of bringing healthcare industry leaders together. This premier two-day healthcare...more
When a doctor suggests that a medical device may help you, they’ll explain a little bit about how the device works; however, truly understanding how any given device works often requires either a medical or scientific...more
Although healthcare M&A activity in Q3 declined slightly from the previous quarter, analysts believe the activity level declined much less than expected given the numerous headwinds—inflation, rising interest rates, labor...more
2022 started strong for healthcare transactions with some reports suggesting a record-breaking January. Although deal activity cooled in February and March, transaction pipelines still indicate that 2022 is on pace to match...more
The Environmental Protection Agency (EPA) has promulgated its proposed regulation of “hazardous waste pharmaceuticals,” i.e., pharmaceutical residues discarded from health care facilities which also meet EPA’s long-standing...more
The 340B Drug Pricing Program (340B Program), established by Section 602 of the Veterans Health Care Act of 1992, is administered by the Health Resources and Services Administration (HRSA) of HHS. The 340B Program requires...more